🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2009-09
Trial ID
NCT01037244
The objective of this study was to verify the efficacy of ASP015K versus pl...
Status
Completed
Location
JP00037
Start Date
2014-07-25
Trial ID
NCT02305849
Treatments Being Tested
This study was designed to estimate the effect of two-year treatment with t...
Status
Completed
Location
Institute for Atherosclerosis Research
Start Date
2004-01
Trial ID
NCT01734707
The purpose of this study is to investigate the safety and pharmacokinetics...
Status
Completed
Location
Clinical Trials Center, Seoul National University Hospital
Start Date
2011-05
Trial ID
NCT01348516
Treatments Being Tested
A study to investigate the analgesic efficacy of AZD2423 compared with plac...
Status
Completed
Location
Research Site
Start Date
2010-09
Trial ID
NCT01201317
Primary Objective: To evaluate the effect of alirocumab (SAR236553/REGN727...
Status
Completed
Location
Investigational Site Number 840616
Start Date
2011-01
Trial ID
NCT01288469
Treatments Being Tested
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01225380
This study will examine whether supplementation with the serotonin and dopa...
Status
Suspended
Location
University of Louisville, Kentucky Spinal Cord Injury Research Centre
Start Date
2019-06-19
Trial ID
NCT04000919
Treatments Being Tested
This trial is intended to study the safety and effectiveness of an new anti...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-10-03
Trial ID
NCT03678753
Treatments Being Tested